EGFR and cancer: A recent study indicated that mice with EGFR mutations are more likely to develop cancer after exposure to pollutant particles mediated by an inflammatory protein called interleukin 1 beta, which is part of the body's immune response to PM2.5 exposure (Swanton et al, 2022).